Method for oral administration of buspirone and nefazodone
US6008222A · kind A · utility
5Cited by
6References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 6, 1997 |
| Grant date | Dec 28, 1999 |
| Priority date | — |
| Expiry date | Nov 6, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An improved method for orally administering buspirone to a human subject wherein the bioavailability of buspirone is increased and its elimination, metabolite formation, and variability of these pharmacokinetic parameters is decreased, the improvement comprises the concurrent administration of a sufficient amount of nefazodone to effect these pharmacokinetic changes for orally administered buspirone.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.